Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$321.00
-3.50-1.08%
At close: -
$321.00
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Insulet Analyst Ratings and Price Targets | NASDAQ:PODD | Benzinga
Insulet Corp has a consensus price target of $300.38 based on the ratings of 27 analysts. The high is $380 issued by Citigroup on May 22, 2025. The low is $184 issued by Leerink Partners on October 16, 2023. The 3 most-recent analyst ratings were released by Citigroup, Wolfe Research, and Oppenheimer on May 22, 2025, May 13, 2025, and May 9, 2025, respectively. With an average price target of $351.33 between Citigroup, Wolfe Research, and Oppenheimer, there's an implied 9.45% upside for Insulet Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
Wolfe Research
Oppenheimer
Barclays
RBC Capital
1calculated from analyst ratings
Analyst Ratings for Insulet
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/22/2025 | Buy Now | 18.38% | Citigroup | Joanne Wuensch75% | $320 → $380 | Maintains | Buy | Get Alert |
| 05/13/2025 | Buy Now | 9.03% | Wolfe Research | Mike Polark57% | → $350 | Upgrade | Peer Perform → Outperform | Get Alert |
| 05/09/2025 | Buy Now | 0.93% | Oppenheimer | Steven Lichtman70% | $312 → $324 | Maintains | Outperform | Get Alert |
| 04/30/2025 | Buy Now | -17.13% | Barclays | Matt Miksic67% | $234 → $266 | Maintains | Equal-Weight | Get Alert |
| 04/29/2025 | Buy Now | — | Wolfe Research | Mike Polark57% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 03/06/2025 | Buy Now | 5.92% | RBC Capital | Shagun Singh58% | → $340 | Initiates | → Outperform | Get Alert |
| 02/21/2025 | Buy Now | 10.59% | Citigroup | Joanne Wuensch75% | $310 → $355 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 2.18% | Raymond James | Jayson Bedford68% | $294 → $328 | Reiterates | Outperform → Outperform | Get Alert |
| 02/21/2025 | Buy Now | -8.72% | Stifel | Mathew Blackman64% | $245 → $293 | Maintains | Hold | Get Alert |
| 02/21/2025 | Buy Now | -3.43% | Piper Sandler | Matt O'Brien53% | $285 → $310 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | 0.31% | Wells Fargo | Lawrence Biegelsen49% | $305 → $322 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | 0.93% | Canaccord Genuity | Kyle Rose31% | $304 → $324 | Maintains | Buy | Get Alert |
| 01/03/2025 | Buy Now | 0.93% | TD Cowen | Joshua Jennings56% | $264 → $324 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | 2.8% | JP Morgan | Robbie Marcus66% | $280 → $330 | Maintains | Overweight | Get Alert |
| 12/11/2024 | Buy Now | -3.43% | Citigroup | Joanne Wuensch75% | $283 → $310 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | -4.98% | Wells Fargo | Lawrence Biegelsen49% | $290 → $305 | Maintains | Overweight | Get Alert |
| 12/09/2024 | Buy Now | -5.3% | Canaccord Genuity | William Plovanic60% | $269 → $304 | Maintains | Buy | Get Alert |
| 11/11/2024 | Buy Now | -27.1% | Barclays | Matt Miksic67% | $220 → $234 | Maintains | Equal-Weight | Get Alert |
| 11/11/2024 | Buy Now | -1.25% | Morgan Stanley | Patrick Wood5% | $234 → $317 | Maintains | Overweight | Get Alert |
| 11/08/2024 | Buy Now | -15.89% | BTIG | Marie Thibault57% | $260 → $270 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | -6.54% | Bernstein | Lee Hambright70% | → $300 | Initiates | → Outperform | Get Alert |
| 10/14/2024 | Buy Now | -19% | Raymond James | Jayson Bedford68% | $213 → $260 | Maintains | Outperform | Get Alert |
| 10/14/2024 | Buy Now | -19% | BTIG | Marie Thibault57% | $250 → $260 | Maintains | Buy | Get Alert |
| 10/01/2024 | Buy Now | -14.33% | Citigroup | Joanne Wuensch75% | $250 → $275 | Maintains | Buy | Get Alert |
| 09/25/2024 | Buy Now | -16.2% | Canaccord Genuity | William Plovanic60% | $236 → $269 | Maintains | Buy | Get Alert |
| 09/17/2024 | Buy Now | -11.21% | Piper Sandler | Matt O'Brien53% | $230 → $285 | Maintains | Overweight | Get Alert |
| 08/12/2024 | Buy Now | -31.46% | Barclays | Matt Miksic67% | $200 → $220 | Maintains | Equal-Weight | Get Alert |
| 08/09/2024 | Buy Now | -22.12% | BTIG | Marie Thibault57% | $270 → $250 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | -30.53% | UBS | Matthew Taylor65% | $211 → $223 | Maintains | Neutral | Get Alert |
| 07/23/2024 | Buy Now | -27.1% | Canaccord Genuity | William Plovanic60% | $234 → $234 | Maintains | Buy | Get Alert |
| 06/10/2024 | Buy Now | — | OTR Global | — | — | Downgrade | Positive → Mixed | Get Alert |
| 05/30/2024 | Buy Now | -26.79% | Redburn Atlantic | Issie Kirby32% | → $235 | Initiates | → Buy | Get Alert |
| 05/13/2024 | Buy Now | -37.69% | Barclays | Matt Miksic67% | $213 → $200 | Maintains | Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | -27.1% | Canaccord Genuity | Kyle Rose31% | $226 → $234 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | -33.64% | Raymond James | Jayson Bedford68% | $218 → $213 | Maintains | Outperform | Get Alert |
| 05/10/2024 | Buy Now | -19% | Jefferies | Matthew Taylor65% | $255 → $260 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | -37.69% | Wolfe Research | Mike Polark57% | → $200 | Upgrade | Peer Perform → Outperform | Get Alert |
| 02/26/2024 | Buy Now | -33.64% | Barclays | Matt Miksic67% | $214 → $213 | Maintains | Equal-Weight | Get Alert |
| 02/23/2024 | Buy Now | -28.35% | Piper Sandler | Matt O'Brien53% | $250 → $230 | Maintains | Overweight | Get Alert |
| 02/23/2024 | Buy Now | -29.91% | JP Morgan | Robbie Marcus66% | $190 → $225 | Maintains | Overweight | Get Alert |
| 02/05/2024 | Buy Now | -35.2% | Stifel | Mathew Blackman64% | $163 → $208 | Maintains | Hold | Get Alert |
| 12/21/2023 | Buy Now | -25.86% | Baird | Jeff Johnson77% | $180 → $238 | Upgrade | Neutral → Outperform | Get Alert |
| 12/04/2023 | Buy Now | -27.1% | Morgan Stanley | Patrick Wood5% | $185 → $234 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/03/2023 | Buy Now | -22.12% | Piper Sandler | Matt O'Brien53% | $325 → $250 | Maintains | Overweight | Get Alert |
| 10/17/2023 | Buy Now | -49.53% | JP Morgan | Robbie Marcus66% | $325 → $162 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | -42.68% | Leerink Partners | Mike Kratky66% | → $184 | Initiates | → Outperform | Get Alert |
| 10/02/2023 | Buy Now | -25.23% | Jefferies | Matthew Taylor65% | $260 → $240 | Upgrade | Hold → Buy | Get Alert |
| 09/29/2023 | Buy Now | -42.37% | Morgan Stanley | Patrick Wood5% | $208 → $185 | Maintains | Equal-Weight | Get Alert |
| 09/15/2023 | Buy Now | -28.97% | Raymond James | Jayson Bedford68% | $299 → $228 | Maintains | Outperform | Get Alert |
| 09/06/2023 | Buy Now | -33.02% | UBS | Matthew Taylor65% | $270 → $215 | Maintains | Neutral | Get Alert |
| 08/24/2023 | Buy Now | -8.1% | B of A Securities | Travis Steed61% | $365 → $295 | Maintains | Buy | Get Alert |
| 08/24/2023 | Buy Now | -35.2% | Morgan Stanley | Patrick Wood5% | $343 → $208 | Maintains | Equal-Weight | Get Alert |
| 08/21/2023 | Buy Now | -17.45% | Citigroup | Joanne Wuensch75% | $273 → $265 | Upgrade | Neutral → Buy | Get Alert |
| 08/21/2023 | Buy Now | -31.78% | Baird | Jeff Johnson77% | $320 → $219 | Downgrade | Outperform → Neutral | Get Alert |
| 08/10/2023 | Buy Now | -19.94% | Barclays | Matt Miksic67% | $329 → $257 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | Buy Now | -6.54% | TD Cowen | Josh Jennings61% | $350 → $300 | Maintains | Outperform | Get Alert |
| 08/09/2023 | Buy Now | 1.25% | JP Morgan | Robbie Marcus66% | $365 → $325 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | -14.95% | Citigroup | Joanne Wuensch75% | $319 → $273 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | 2.8% | Wells Fargo | Lawrence Biegelsen49% | $375 → $330 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | -6.85% | Raymond James | Jayson Bedford68% | $350 → $299 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | -0.62% | Citigroup | Joanne Wuensch75% | $330 → $319 | Maintains | Neutral | Get Alert |
| 05/30/2023 | Buy Now | 6.85% | Morgan Stanley | Patrick Wood5% | → $343 | Assumes | → Equal-Weight | Get Alert |
| 05/08/2023 | Buy Now | 2.49% | Barclays | Matt Miksic67% | $292 → $329 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | 6.85% | Morgan Stanley | Cecilia Furlong51% | $325 → $343 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | 9.03% | Raymond James | Jayson Bedford68% | $334 → $350 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 12.15% | Piper Sandler | Matt O'Brien53% | $340 → $360 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | 15.26% | Baird | Jeff Johnson77% | $350 → $370 | Maintains | Outperform | Get Alert |
| 04/20/2023 | Buy Now | 6.54% | Stifel | Mathew Blackman64% | $300 → $342 | Maintains | Hold | Get Alert |
| 04/17/2023 | Buy Now | 9.03% | BTIG | Ryan Zimmerman71% | $340 → $350 | Maintains | Buy | Get Alert |
| 02/24/2023 | Buy Now | 4.05% | Raymond James | Jayson Bedford68% | $320 → $334 | Maintains | Outperform | Get Alert |
| 02/24/2023 | Buy Now | 1.25% | Morgan Stanley | Cecilia Furlong51% | $320 → $325 | Maintains | Equal-Weight | Get Alert |
| 02/24/2023 | Buy Now | 9.03% | Baird | Jeff Johnson77% | $340 → $350 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | — | Wolfe Research | Mike Polark57% | — | Initiates | → Peer Perform | Get Alert |
| 01/06/2023 | Buy Now | -0.31% | Morgan Stanley | Cecilia Furlong51% | $300 → $320 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | -6.54% | Morgan Stanley | David Lewis71% | $273 → $300 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | -1.87% | Baird | Jeff Johnson77% | $300 → $315 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | -0.31% | Raymond James | Jayson Bedford68% | $280 → $320 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | 5.92% | Piper Sandler | Matt O'Brien53% | $235 → $340 | Upgrade | Neutral → Overweight | Get Alert |
| 10/18/2022 | Buy Now | -25.86% | Barclays | Matt Miksic67% | → $238 | Initiates | → Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | -19% | Jefferies | Matthew Taylor65% | → $260 | Initiates | → Hold | Get Alert |
| 08/22/2022 | Buy Now | -3.43% | TD Cowen | Josh Jennings61% | → $310 | Maintains | Outperform | Get Alert |
| 08/08/2022 | Buy Now | -14.95% | Morgan Stanley | David Lewis71% | $244 → $273 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | Buy Now | -9.66% | Canaccord Genuity | Kyle Rose31% | $250 → $290 | Maintains | Buy | Get Alert |
| 08/05/2022 | Buy Now | -6.54% | Baird | Jeff Johnson77% | $245 → $300 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | -12.77% | Raymond James | Jayson Bedford68% | $262 → $280 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | -26.79% | Piper Sandler | Matt O'Brien53% | $230 → $235 | Maintains | Neutral | Get Alert |
| 07/11/2022 | Buy Now | -22.12% | Citigroup | Joanne Wuensch75% | $310 → $250 | Downgrade | Buy → Neutral | Get Alert |
| 06/24/2022 | Buy Now | -22.12% | BTIG | Marie Thibault57% | $310 → $250 | Maintains | Buy | Get Alert |
| 06/07/2022 | Buy Now | -23.99% | Morgan Stanley | David Lewis71% | $268 → $244 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Insulet (PODD) stock?
The latest price target for Insulet (NASDAQ:PODD) was reported by Citigroup on May 22, 2025. The analyst firm set a price target for $380.00 expecting PODD to rise to within 12 months (a possible 18.38% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Insulet (PODD)?
The latest analyst rating for Insulet (NASDAQ:PODD) was provided by Citigroup, and Insulet maintained their buy rating.
When was the last upgrade for Insulet (PODD)?
The last upgrade for Insulet Corp happened on May 13, 2025 when Wolfe Research raised their price target to $350. Wolfe Research previously had a peer perform for Insulet Corp.
When was the last downgrade for Insulet (PODD)?
The last downgrade for Insulet Corp happened on April 29, 2025 when Wolfe Research changed their price target from N/A to N/A for Insulet Corp.
When is the next analyst rating going to be posted or updated for Insulet (PODD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insulet, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insulet was filed on May 22, 2025 so you should expect the next rating to be made available sometime around May 22, 2026.
Is the Analyst Rating Insulet (PODD) correct?
While ratings are subjective and will change, the latest Insulet (PODD) rating was a maintained with a price target of $320.00 to $380.00. The current price Insulet (PODD) is trading at is $321.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
